Three Startups Each win CHF 40,000: RatioX, Swiss Medical Union and deepCDR Biologics
Summary
Product design engineer and IMD MBA graduate Simon Faneco founded ratioX to develop a bicycle transmission system that means riders never need to change gear. This user-friendly product simplifies cycling and is low maintenance, making it ideal for commuters and cyclists who value reliable and practical mobility. Swiss Medical Union team, Daniil Golubev - CEO & Founder, Marion Argi – CMO and Andrew Alikimovitch, CTO from the University of Geneva (UNIGE) is leveraging an ex-vivo platform to predict individual in vivo results via a micro- bioreactor and simulation software. The Venture Kick funds will be used to get the CE Mark for Bioreactor & Test, a clinical evaluation and an Adaptation of Bioreactor from minimum viable product to full product.Currently, drug-developers searching for new therapeutic antibodies use time-consuming, experimental screening processes that can take years to develop candidates ready for clinical trial. This ETH-spinoffs patented discovery workflow combines drug screening in mammalian cells with deep learning to generate thousands of optimized lead candidates at ten-times the speed of current technology, focusing on the $100 billion monoclonal antibody market.